RAMAN GOPALAKRISHNAN: Open Payments
NPI 1982688271 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,403 in 128 payments from 16 companies in 2025. Trend: 2023 $2,170 · 2024 $2,500 · 2025 $2,403
Food & beverage: $2,302Education: $101
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $494 |
| Axsome Therapeutics, Inc. | 25 | $361 |
| Neurocrine BioSciences, Inc. | 15 | $323 |
| ABBVIE INC. | 16 | $207 |
| Alkermes, Inc. | 9 | $180 |
| Teva Pharmaceuticals USA, Inc. | 7 | $178 |
| Vanda Pharmaceuticals Inc. | 8 | $172 |
| Almatica Pharma LLC | 7 | $151 |
| Bausch Health US, LLC | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
Products named: CAPLYTA, Auvelity, INGREZZA, VRAYLAR, ARISTADA, FANAPT, LOREEV XR, APLENZIN.
Industry payments across PA — which companies pay providers there.
